S
SUPN
Supernus Pharma
42.67
+0.53+1.26%After Hours: 42.67 0.00 0.00%19:30 10/09 EDT
OPEN/PREV CLOSE42.18/42.14
TODAY RANGE42.15-43.14
VOL643.83K
MARKET CAP2.48B
52 WEEK RANGE40.51-59.68
AVG VOL (3M)749.52K
% TURNOVER0.90%
TURNOVER--
P/E (TTM)-22.2901
% RANGE2.33%
EPS(TTM)-1.9143
P/E(FORWARD)-213.3500
P/B2.407
BVPS17.73
DIVIDEND--
P/S3.410
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.38B
SHARES OUTSTANDING58.22M
NEXT EARNINGS11/02-11/11
FREE FLOAT55.71M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/18 14:10
10 mid-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha·08/31 18:57
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
NASDAQ·08/21 16:40
Indivior's Supernus Merger Could Broaden Its Growth Engine in 2026
NASDAQ·08/21 14:48
Should Investors Buy INDV as Sublocade Growth Meets Rising Risks?
Benzinga·08/17 09:20
Supernus Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript
Seeking Alpha·08/09 14:46
Key deals this week: Bending Spoons, Advanced Micro Devices, Visa, Prologis, and more
NASDAQ·08/07 15:40
SUPN vs. TEVA: Which Stock Should Value Investors Buy Now?
NASDAQ·08/07 08:46
New Strong Buy Stocks for August 7th
Seeking Alpha·08/07 07:55
Carillon Chartwell Small Cap Growth Fund Q2 2026 Portfolio Review
NASDAQ·08/07 07:45
Best Value Stocks to Buy for August 7th
Benzinga·08/04 10:04
Top 3 Health Care Stocks You'll Regret Missing This Quarter
TipRanks·08/03 22:27
Supernus, Indivior Launch Communications on Proposed Merger
Seeking Alpha·08/03 19:44
Supernus And Indivior Merger: There May Be Some Skepticism, But I Have Faith In This Deal
Same Industry